Summary Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic
polypeptide (GIP) are incretins that stimulate insulin secretion from pancreatic β cells in …

Weight regain after successful weight loss resulting from lifestyle interventions is a major
challenge in the management of overweight and obesity. Knowledge of the causal …

Caloric restriction that promotes weight loss is an effective strategy for treating non-alcoholic
fatty liver disease and improving insulin sensitivity in people with type 2 diabetes. Despite its …

Amylin (also called islet amyloid polypeptide (IAPP)) is a pancreatic beta-cell hormone that
is co-secreted with insulin in response to nutrient stimuli. The last 35 years of intensive …

Objective Glucagon-like peptide 1 (GLP-1) receptor agonists reduce food intake, producing
remarkable weight loss in overweight and obese individuals. While much of this weight loss …

Older patients are prone to multimorbidity or related polypharmacy, which may cause
various adverse drug reactions (ADRs) and a high incidence of drug‐related health …

Research investigating the effects of the food matrix on health is needed to untangle many
unresolved questions in nutritional science. Emulsion structure plays a fundamental role in …

Objective This study tested the hypothesis that treatment with the glucagon‐like peptide‐
1/glucagon receptor agonist SAR425899 would lead to a smaller decrease in sleeping …

Background: Black garlic, also known as fermented garlic, is a useful food that may have
therapeutic benefits. The aim of this study was to analyze the impact of fermented garlic and …

Increasing leptin resistance and methylglyoxal (MG) levels have been observed in patients
with obesity, which is characterized by an imbalance in energy metabolism and abnormal fat …